AbbVie (ABBV)

Outperform Current rating · 4 reports

2026-04-30

Outperform Recap: Q1 2026

The Confirming Quarter Arrives: Aesthetics Troughs, the Engines Re-Accelerate, and the Tape Finally Rewards the Beat — Upgrading to Outperform After Three Disciplined Holds.

2026-02-05

Hold Recap: Q4 2025

A Beat-and-Raise the Tape Sold Again: 2026’s Re-Acceleration Is Half-Funded by an IPR&D Definition Change — Maintaining Hold, One Clean Quarter From an Upgrade

2025-11-01

Hold Recap: Q3 2025

A $1.50 IPR&D Charge Makes a Strong Quarter Look Like a Collapse — But the Real Story Is a 21% Run-Up Meeting a Full Price. Maintaining Hold.

2025-08-01

Hold Recap: Q2 2025

The Ex-Humira Engine Is Firing on All Cylinders, But a +4% Gap That Faded to Flat Tells You the Price Already Knows It — Initiating at Hold